CoChat

Retinoic Acid Signalling and the Control of Meiotic Entry in the Human Fetal Gonad

Open access

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

The development of mammalian fetal germ cells along oogenic or spermatogenic fate trajectories is dictated by signals from the surrounding gonadal environment. Germ cells in the fetal testis enter mitotic arrest, whilst those in the fetal ovary undergo sex-specific entry into meiosis, the initiation of which is thought to be mediated by selective exposure of fetal ovarian germ cells to mesonephros-derived retinoic acid (RA). Aspects of this model are hard to reconcile with the spatiotemporal pattern of germ cell differentiation in the human fetal ovary, however. We have therefore examined the expression of components of the RA synthesis, metabolism and signalling pathways, and their downstream effectors and inhibitors in germ cells around the time of the initiation of meiosis in the human fetal gonad. Expression of the three RA-synthesising enzymes, ALDH1A1, 2 and 3 in the fetal ovary and testis was equal to or greater than that in the mesonephros at 8-9 weeks gestation, indicating an intrinsic capacity within the gonad to synthesise RA. Using immunohistochemistry to detect RA receptors RARα, β and RXRα, we find germ cells to be the predominant target of RA signalling in the fetal human ovary, but also reveal widespread receptor nuclear localization indicative of signalling in the testis, suggesting that human fetal testicular germ cells are not efficiently shielded from RA by the action of the RA-metabolising enzyme CYP26B1. Consistent with this, expression of CYP26B1 was greater in the human fetal ovary than testis, although the sexually-dimorphic expression patterns of the germ cell-intrinsic regulators of meiotic initiation, STRA8 and NANOS2, appear conserved. Finally, we demonstrate that RA induces a two-fold increase in STRA8 expression in cultures of human fetal testis, but is not sufficient to cause widespread meiosis-associated gene expression. Together, these data indicate that while local production of RA within the fetal ovary may be important in regulating the onset of meiosis in the human fetal ovary, mechanisms other than CYP26B1-mediated metabolism of RA may exist to inhibit the entry of germ cells into meiosis in the human fetal testis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0020249

Cites

Statistics

Figures

Figure 1 Expression of genes encoding retinaldehyde dehydrogenase enzymes in the human fetal gonad. qRT-PCR analysis reveals developmentally regulated expression of ALDH1A1 (A) in the human fetal testis, with transcript levels increasing significantly between 8–9 weeks gestation and 14–16/17–20 weeks gestation (ANOVA; a,b,c; p<0.05, n = 5–6 per group). Expression was not significantly different between gonads of different sexes at the same developmental stage, not between ovaries at different gestational ages. ALDH1A2 expression (B) is also developmentally-regulated in the human fetal testis, with transcript levels in the first trimester (8–9 weeks gestation) testis significantly higher than those in the early second trimester (14–16 weeks) testis (a vs b, p<0.05) and the late second trimester (17–20 weeks) testis (a vs c, p<0.01). Expression in the testis at 8–9 weeks gestation was also significantly higher than that in the fetal ovary at the same developmental stage (a vs d, p<0.05). ALDH1A2 transcript levels were also higher in the 8–9 week human fetal testis than in mesonephroi from age-matched fetuses (a vs e, p<0.01), which contrasts with the mesonephric-specific expression of Aldh1a2 in the mouse at a comparable developmental stage. No differences in the expression of ALDH1A3 (C) were detected between samples of different gestational ages of the same sex, or between the gonads of different sexes at the same developmental stage. 8–9, 14–16 and 17–20 denote the gestational age (in weeks) of specimens, meso: 8–9 week mesonephroi (pooled male and female). Values denote mean ± s.e.m..
Figure 1 Expression of genes encoding retinaldehyde dehydrogenase enzymes in the human fetal gonad. qRT-PCR analysis reveals developmentally regulated expression of ALDH1A1 (A) in the human fetal testis, with transcript levels increasing significantly between 8–9 weeks gestation and 14–16/17–20 weeks gestation (ANOVA; a,b,c; p<0.05, n = 5–6 per group). Expression was not significantly different between gonads of different sexes at the same developmental stage, not between ovaries at different gestational ages. ALDH1A2 expression (B) is also developmentally-regulated in the human fetal testis, with transcript levels in the first trimester (8–9 weeks gestation) testis significantly higher than those in the early second trimester (14–16 weeks) testis (a vs b, p<0.05) and the late second trimester (17–20 weeks) testis (a vs c, p<0.01). Expression in the testis at 8–9 weeks gestation was also significantly higher than that in the fetal ovary at the same developmental stage (a vs d, p<0.05). ALDH1A2 transcript levels were also higher in the 8–9 week human fetal testis than in mesonephroi from age-matched fetuses (a vs e, p<0.01), which contrasts with the mesonephric-specific expression of Aldh1a2 in the mouse at a comparable developmental stage. No differences in the expression of ALDH1A3 (C) were detected between samples of different gestational ages of the same sex, or between the gonads of different sexes at the same developmental stage. 8–9, 14–16 and 17–20 denote the gestational age (in weeks) of specimens, meso: 8–9 week mesonephroi (pooled male and female). Values denote mean ± s.e.m..CC BY · PubMed Central
Figure 2 Expression of genes encoding retinoic acid and retinoid receptors in the human fetal gonad. qRT-PCR analysis of expression of the genes encoding the retinoic acid (RARα (A), RARβ (B) and RARγ (C) and retinoid (RXRα (D), RXRβ (E) and RXRγ (F)) in the human fetal testis and ovary. No significant differences in levels encoding any of the receptor isoforms were detected between samples of different gestational ages within the same sex, or in gonads of different sexes at the same developmental age, indicating that RAR/RXR receptor expression is not developmentally-regulated in the human fetal gonad. Values denote mean ± s.e.m; 8–9, 14–16 and 17–20 denotes gestational age (in weeks) of specimens.
Figure 2 Expression of genes encoding retinoic acid and retinoid receptors in the human fetal gonad. qRT-PCR analysis of expression of the genes encoding the retinoic acid (RARα (A), RARβ (B) and RARγ (C) and retinoid (RXRα (D), RXRβ (E) and RXRγ (F)) in the human fetal testis and ovary. No significant differences in levels encoding any of the receptor isoforms were detected between samples of different gestational ages within the same sex, or in gonads of different sexes at the same developmental age, indicating that RAR/RXR receptor expression is not developmentally-regulated in the human fetal gonad. Values denote mean ± s.e.m; 8–9, 14–16 and 17–20 denotes gestational age (in weeks) of specimens.CC BY · PubMed Central
Figure 3 Immunohistochemical localisation of retinoid receptor expression in the human fetal gonad. In the second trimester human fetal testis (A) RARα staining was detected in germ cell (GC) and peritubular myoid (PTM) nuclei. Two populations of Sertoli cells (SC; immunopositive and immunonegative) could also be detected. In the fetal ovary at the same developmental stage (B), RARα expression was detected in the nuclei and cytoplasm of germ cells in nests, and in the nuclei of pregranulosa cells (PG) interspersed between germ cells. Mesenchymal somatic cells in streams (CS) displayed variable staining. RARβ expression was widespread in the fetal testis (C) with all major cell populations displaying intense nuclear staining. In contrast, variable RARβ expression was detected in the germ cells of the fetal ovary (D); with some displaying intensely stained nuclei or both nuclear and cytoplasmic staining (solid arrows) and others showing little or no staining (dashed arrows). Pregranulosa cells were immunonegative, as were somatic cells in streams, although some displayed nuclear staining for RARβ (arrowheads). Peritubular myoid and Sertoli cell nuclei in the testes displayed intense staining for RARβ (E), with weaker expression in detected in germ cells. A population of immunonegative IC was also detected. The distribution of immunostaining for RXRα in the fetal ovary (F) was comparable to that of RARβ, with expression restricted to germ cells in nests (GCn) and absent in somatic cell streams and pregranulosa cells. The widespread nuclear localization of RA receptors in testis suggests cells of all types (including germ cells) are exposed to RA signals. Magnification: 400× (A, B), 1000× (C–F).
Figure 3 Immunohistochemical localisation of retinoid receptor expression in the human fetal gonad. In the second trimester human fetal testis (A) RARα staining was detected in germ cell (GC) and peritubular myoid (PTM) nuclei. Two populations of Sertoli cells (SC; immunopositive and immunonegative) could also be detected. In the fetal ovary at the same developmental stage (B), RARα expression was detected in the nuclei and cytoplasm of germ cells in nests, and in the nuclei of pregranulosa cells (PG) interspersed between germ cells. Mesenchymal somatic cells in streams (CS) displayed variable staining. RARβ expression was widespread in the fetal testis (C) with all major cell populations displaying intense nuclear staining. In contrast, variable RARβ expression was detected in the germ cells of the fetal ovary (D); with some displaying intensely stained nuclei or both nuclear and cytoplasmic staining (solid arrows) and others showing little or no staining (dashed arrows). Pregranulosa cells were immunonegative, as were somatic cells in streams, although some displayed nuclear staining for RARβ (arrowheads). Peritubular myoid and Sertoli cell nuclei in the testes displayed intense staining for RARβ (E), with weaker expression in detected in germ cells. A population of immunonegative IC was also detected. The distribution of immunostaining for RXRα in the fetal ovary (F) was comparable to that of RARβ, with expression restricted to germ cells in nests (GCn) and absent in somatic cell streams and pregranulosa cells. The widespread nuclear localization of RA receptors in testis suggests cells of all types (including germ cells) are exposed to RA signals. Magnification: 400× (A, B), 1000× (C–F).CC BY · PubMed Central
Figure 4 Conserved and divergent patterns of expression of STRA8, CYP26B1 and NANOS1-3 in the human fetal gonad. qRT-PCR analysis of human fetal gonads reveals female-biased and developmentally-regulated expression of STRA8 (A). STRA8 expression increased significantly between 8–9 and 14–16 weeks in the human fetal ovary (a vs b, p<0.05) consistent with the initiation of meiosis in the fetal ovary around 11 weeks gestation. Levels of transcripts encoding STRA8 were low and not significantly different between human fetal testes and ovaries at 8–9 weeks gestation, but were significantly higher in fetal ovaries than fetal testes at 14–16 weeks (c vs d, p<0.0001) and 17–20 weeks (e vs f, p = 0.008). CYP26B1 (B) expression was not significantly different between samples of the same sex at different gestational ages, but was significantly higher at in the fetal ovary than the fetal testis at 14–16 weeks (a vs b, p = 0.02); suggesting the male-specific expression of CYP26B1 reported in mice at a comparable developmental stage is not conserved to humans. NANOS2 (C) expression was predominantly male-specific and developmentally-regulated, with expression increasing in the human fetal testis with increasing gestational age (a,b,c, p<0.001). NANOS2 expression was also significantly higher in fetal testes than ovaries at 14–16 weeks (d vs e, p = 0.01) and 17–20 weeks (f vs g, p<0.01), a result consistent with a role for this protein in repressing meiosis in the fetal male germline. 8–9, 14–16 and 17–20 denote gestation age (in weeks) of specimens. No differences were detected in the expression of NANOS1 (D) between testis and ovaries at any gestational age, nor between gonads of the same sex at any developmental stage. NANOS3 expression (E) was significantly higher in the human fetal ovary at 14–16 weeks gestation than at 8–9 weeks gestation (a vs b, p<0.05), in contrast to the downregulation of the homologous gene in the fetal mouse ovary at the comparable developmental stage. Expression of NANOS3 was also greater in the fetal ovary than in the fetal testis at 14–16 weeks (c vs d, p<0.05) and 17–20 weeks (e vs f, p<0.02). 8–9, 14–16 and 17–20 denote the gestational age (in weeks) of specimens, values denote mean ± s.e.m, 8–9, 14–16 and 17–20 denote the gestational age (in weeks) of specimens.
Figure 4 Conserved and divergent patterns of expression of STRA8, CYP26B1 and NANOS1-3 in the human fetal gonad. qRT-PCR analysis of human fetal gonads reveals female-biased and developmentally-regulated expression of STRA8 (A). STRA8 expression increased significantly between 8–9 and 14–16 weeks in the human fetal ovary (a vs b, p<0.05) consistent with the initiation of meiosis in the fetal ovary around 11 weeks gestation. Levels of transcripts encoding STRA8 were low and not significantly different between human fetal testes and ovaries at 8–9 weeks gestation, but were significantly higher in fetal ovaries than fetal testes at 14–16 weeks (c vs d, p<0.0001) and 17–20 weeks (e vs f, p = 0.008). CYP26B1 (B) expression was not significantly different between samples of the same sex at different gestational ages, but was significantly higher at in the fetal ovary than the fetal testis at 14–16 weeks (a vs b, p = 0.02); suggesting the male-specific expression of CYP26B1 reported in mice at a comparable developmental stage is not conserved to humans. NANOS2 (C) expression was predominantly male-specific and developmentally-regulated, with expression increasing in the human fetal testis with increasing gestational age (a,b,c, p<0.001). NANOS2 expression was also significantly higher in fetal testes than ovaries at 14–16 weeks (d vs e, p = 0.01) and 17–20 weeks (f vs g, p<0.01), a result consistent with a role for this protein in repressing meiosis in the fetal male germline. 8–9, 14–16 and 17–20 denote gestation age (in weeks) of specimens. No differences were detected in the expression of NANOS1 (D) between testis and ovaries at any gestational age, nor between gonads of the same sex at any developmental stage. NANOS3 expression (E) was significantly higher in the human fetal ovary at 14–16 weeks gestation than at 8–9 weeks gestation (a vs b, p<0.05), in contrast to the downregulation of the homologous gene in the fetal mouse ovary at the comparable developmental stage. Expression of NANOS3 was also greater in the fetal ovary than in the fetal testis at 14–16 weeks (c vs d, p<0.05) and 17–20 weeks (e vs f, p<0.02). 8–9, 14–16 and 17–20 denote the gestational age (in weeks) of specimens, values denote mean ± s.e.m, 8–9, 14–16 and 17–20 denote the gestational age (in weeks) of specimens.CC BY · PubMed Central
Figure 5 Retinoic acid promotes the expression of STRA8 but not other meiosis-associated genes in the second trimester human fetal testis. Human fetal testis (14–15 weeks gestation) were disaggregated to a single cell suspension and cultured in serum free medium in the presence of vehicle (DMSO) or 1 µM all trans retinoic acid (1 µM RA in DMSO) for 24 hours. RA treatment induced a 2.2±0.3 fold increase in the expression of STRA8 (A) relative to vehicle treated controls (a vs b, p<0.05, n = 5), indicating that RA-regulated expression of this gene is conserved in human fetal gonads. No significant differences in the expression of meiosis markers SYCP3 (B, n.s. n = 6) or DMC1 (C, n = 6, n.s.) were detected between RA- and vehicle-treated cultures, indicating that whilst RA can stimulate STRA8 expression, it is not sufficient to cause widespread activation of the meiosis-associated gene expression programme. Values denote mean ± s.e.m..
Figure 5 Retinoic acid promotes the expression of STRA8 but not other meiosis-associated genes in the second trimester human fetal testis. Human fetal testis (14–15 weeks gestation) were disaggregated to a single cell suspension and cultured in serum free medium in the presence of vehicle (DMSO) or 1 µM all trans retinoic acid (1 µM RA in DMSO) for 24 hours. RA treatment induced a 2.2±0.3 fold increase in the expression of STRA8 (A) relative to vehicle treated controls (a vs b, p<0.05, n = 5), indicating that RA-regulated expression of this gene is conserved in human fetal gonads. No significant differences in the expression of meiosis markers SYCP3 (B, n.s. n = 6) or DMC1 (C, n = 6, n.s.) were detected between RA- and vehicle-treated cultures, indicating that whilst RA can stimulate STRA8 expression, it is not sufficient to cause widespread activation of the meiosis-associated gene expression programme. Values denote mean ± s.e.m..CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 36 · Cited by 157

Research works printed but not linked: 1

  1. J Polkinghorne, 1989, Review of the Guidance on the Research Use of Fetuses and Fetal Material

Metadata

Authors
Childs, A. J., Cowan, G., Kinnell, H. L., Anderson, R. A., & Saunders, P. T. K.
Affiliations
The Queen's Medical Research Institute (GB)
Corresponding author
Childs, Andrew J.
Venue
PLoS ONE
Published
2011-06-03
Volume
6
Issue
6
Pages
e20249
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1987371142
Cited by
157
References
36
Citations by year
2026: 4 · 2025: 6 · 2024: 3 · 2023: 5 · 2022: 15 · 2021: 11 · 2020: 8 · 2019: 15 · 2018: 5 · 2017: 12 · 2016: 15 · 2015: 12 · 2014: 14 · 2013: 13 · 2012: 15
FWCI
9.18
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
  • RVC Research Online (Royal Veterinary College) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
Funders
  • Medical Research Scotland (354FRG)
  • Medical Research Council (U.1276.00.002.00001)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
  • Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
Keywords
retinoic acid signaling, meiotic entry, human fetal ovary, human fetal testis, germ cell differentiation, CYP26B1, retinoic acid receptor, Stra8, Nanos2, mesonephros, oogenesis, spermatogenesis, germ cell fate
MeSH terms
Retinoic Acid 4-Hydroxylase, Animals, Cytochrome P-450 Enzyme System, Female, Fetus, Gene Expression Regulation, Germ Cells, Humans, Male, Meiosis, Ovary, Pregnancy, Pregnancy Trimester, Second, Proteins, Sex Characteristics, Testis, Tretinoin, Signal Transduction, RNA-Binding Proteins, Receptors, Retinoic Acid, Protein Transport, Adaptor Proteins, Signal Transducing, Retinal Dehydrogenase, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Retinoic Acid Signalling and the Control of Meiotic Entry in the Human Fetal Gonad. https://app.cochat.ai/papers/10.1371/journal.pone.0020249
The paper
Childs, A. J., Cowan, G., Kinnell, H. L., Anderson, R. A., & Saunders, P. T. K. (2011). Retinoic Acid Signalling and the Control of Meiotic Entry in the Human Fetal Gonad. PLoS ONE. https://doi.org/10.1371/journal.pone.0020249

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.